Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Gadget Review on MSN
First human receives reverse-aging drug in groundbreaking trial
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...
4 天on MSN
Sci-Fi Becomes Reality: In A Historic Medical Milestone, First Human Receives Reverse-Aging Drug
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...
Weight loss drugs show signs of slowing biological aging, scientists discover - GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果